The pivotal trial supporting its 2010 FDA approval enrolled 816 HIV-infected adults with clinically defined lipodystrophy, and Phase 3 data documented visceral fat reductions of roughly 15-18% over 26 weeks of treatment a result robust enough to clear FDA review for a defined medical indication
Within sensible limits, the basics help your body hold its levels: a diet that includes B12 sources if you are not vegan, limiting heavy alcohol use, and not smoking, since both affect how you absorb and store nutrients
Mayo Clinic Staff
At the molecular level, reduced NNMT activity shifts cellular methylation patterns, potentially altering epigenetic modifications via changes in SAM/S-adenosylhomocysteine (SAH) ratios
This helps make sure treatment works well
Navigating the Good, Bad, and Alternative